Bridgefront Capital, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1725690 AUSTIN, TX

Position in UTHR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$789,446

+$472,795 QoQ

Shares Held

1,457

+172.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#496

of 870 holders

Holding Since

Sep 2022

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgefront Capital, LLC holds $2,674,930 across 3 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (29.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	31,649	$1,658,407
2	UTHR	UNITED THERAPEUTICS Corp This page	1,457	$789,446
3	TLRY	Tilray Brands, Inc.	50,574	$227,077

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$789,446	1,457	+172.8%	Shares	Sole	2026-08-14
2026-03-31	$316,651	534	-88.1%	Shares	Sole	2026-05-15
2025-12-31	$2,180,443	4,475	+65.3%	Shares	Sole	2026-02-13
2025-09-30	$1,135,220	2,708	-17.7%	Shares	Sole	2025-11-14
2025-06-30	$945,668	3,291	+255.8%	Shares	Sole	2025-08-14
2023-12-31	$203,398	925	-36.9%	Shares	Sole	2024-02-14
2022-09-30	$307,160	1,467	—	Shares	Sole	2022-11-29
No filing history on record for this holder in this stock.